Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides
K Kaneda-Nakashima, Y Shirakami… - International Journal of …, 2024 - mdpi.com
Currently, targeted alpha therapy (TAT) is a new therapy involving the administration of a
therapeutic drug that combines a substance of α-emitting nuclides that kill cancer cells and a …
therapeutic drug that combines a substance of α-emitting nuclides that kill cancer cells and a …
Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics …
The aim of the present study consists of the evaluation of the biodistribution of a novel 68Ga-
labeled radiopharmaceutical,[68Ga] Ga-NODAGA-Z360, injected into Balb/c nude mice …
labeled radiopharmaceutical,[68Ga] Ga-NODAGA-Z360, injected into Balb/c nude mice …
Editorial for the Special Issue “Molecular Biology in Targeted Radionuclide Therapy Radiopharmaceutical Design”
Targeted radionuclide therapy (TRT) is gaining wide and rapid acceptance in clinical
practice as it can deliver alpha or beta irradiation to a tumor-associated target which may be …
practice as it can deliver alpha or beta irradiation to a tumor-associated target which may be …